A 12 weeks, randomized and double-blind evaluation of the efficacy of oral supplements of probiotics (Lactogut and Lactogut Kidz) on atopic dermatitis in adults and children


  • B. S. Chandrashekar Department of Dermatology, Cutis Academy of Cutaneous Sciences, Bangalore, Karnataka, India
  • Rashmi Agarwal Department of Dermatology, Cutis Academy of Cutaneous Sciences, Bangalore, Karnataka, India
  • Preethi B. Nayak Department of Dermatology, Cutis Academy of Cutaneous Sciences, Bangalore, Karnataka, India
  • S. Vijayraghavan Tenshi Life Care, Bangalore, Karnataka, India
  • Atul A. Deshmukh Center for Interdisciplinary Research, D. Y. Patil University, Navi Mumbai, Maharashtra, India




Atopic dermatitis, SCORAD, Probiotics


Background: The primary objective of the study was to evaluate the efficacy and safety of oral probiotics in the treatment of atopic dermatitis (AD) using the scoring atopic dermatitis (SCORAD) index, serum IgE levels and absolute eosinophil count (AEC). The secondary objective of the study was to determine the association of oral probiotic therapy and improvement in AD using global photographs, dermoscopic images (fotofinder) and individual patient satisfaction.

Methods: This was a randomized, double-blind study conducted on 70 patients (20 adults and 50 children) with moderate to severe AD. The participants were randomized into control arm and treatment arm. The treatment arm received conventional and probiotic therapy and only conventional therapy was provided to the control arm. The research was carried out in five visits. For each visit, SCORAD was calculated and response compared using clinical and videodermoscopic images. Patient satisfaction was documented using a quality of life questionnaire during each visit.

Results: Across the treatment arm, the mean serum IgE levels were greatly decreased in contrast to the control arm over the 12 weeks period. SCORAD score was significantly lowered in the treatment arm (55.20%) compared with 18.95% in the control arm. Dermoscopic assessment, global photographic assessment and patient satisfaction in the treatment arm showed statistically significant improvement in AD compared to the control arm.

Conclusions: The decrease in SCORAD scores demonstrated strong associations with the use of probiotics in patients with AD as an adjunct to conventional therapy. Thus, in both adults and children suffering from moderate to severe AD, probiotic supplement can be administered effectively as an adjunct therapy.



Rajagopalan M, De A, Godse K, Shankar KDS, Zawar V, Sharma N, et al. Guidelines on management of atopic dermatitis in India: an evidence‑based review and an expert consensus. Indian J Dermatol. 2019;64:166-81.

Kanwar AJ. Adult-onset atopic dermatitis. Indian J Dermatol. 2016;61:662-3.

Kapur S, Watson W, Carr S. Atopic dermatitis. Allergy Asthma Clin Immunol. 2018;14(2):43-52.

Pedersen TK. Clinical aspects of atopic dermatitis. Clin Exp Dermatol. 2000;25(7):535-43.

Thomsen SF. Atopic dermatitis: Natural history, diagnosis and treatment: Review article. ISRN Allergy. 2014;354250:1-7.

Stalder JF, Taieb A, Atherton DJ, Bieber T, Bonifazi E, Broger A, et al. Severity scoring of atopic dermatitis: the SCORAD index. Consensus report of the European Task Force on Atopic Dermatitis. Dermatology. 1993;186:23-31.

Kachagia M, Basoulis D, Konstantopoulou S, Dimitriadi D, Gyftopoulou K, Skarmoutsou N, et al. Health benefits of probioics: a review. ISRN Nutrition. 2013;481651:1-7.

Gill HS, Guarner F. Probiotics and human health: a clinical perspective. Postgrad Med J. 2004;80:516-26.

Huang R, Ning H, Minxue S, Li j, Zhang J, Chen X. Probiotics for the treatment of Atopic Dermatitis in Children: a systmatic review and meta-analysis of randomized controlled trials. Front Cell Infect Microbiol. 2017;7(391):1-11.

Wu KG, Li TH, Peng HJ. Lactobacillus salivarius plus fructooligosaccharide is superior to fructo-oligosaccharide alone for treating children with moderate to severe atopic dermatitis: a double-blind, randomized, clinical trial of efficacy and safety. Br J Dermatol. 2012;166(1):129-36.

Yesilova Y, Calka O, Akdeniz N, Berktaş M. Effect of probiotics on the treatment of children with atopic dermatitis. Ann Dermatol. 2012;24(2):189-93.

Wang IJ, Wang JY. Children with atopic dermatitis show clinical improvement after Lactobacillus exposure. Clin Exp Allergy. 2015;45(4):779-87.

Woo SI, Kim JY, Lee YJ, Kim NS, Hahn YS. Effect of Lactobacillus sakei supplementation in children with atopic eczema-dermatitis syndrome. Ann Allergy Asthma Immunol. 2010;104(4):343-8.

Han Y, Kim B, Ban J, Lee J, Kim BJ, Choi BS, et al. A randomized trial of Lactobacillus plantarum CJLP133 for the treatment of atopic dermatitis. Pediatr Allergy Immunol. 2012;23(7):667-73.

Gerasimov SV, Vasjuta VV, Myhovych OO, Bondarchuk LI. Probiotic supplement reduces atopic dermatitis in preschool children: a randomized, double-blind, placebo-controlled, clinical trial. Am J Clin Dermatol. 2010;11(5):351-61.

Drago L, Iemoli E, Rodighiero V, Nicola L, Vecchi DE, Piconi S. Effects of Lactobacillus salivarius LS01 (DSM 22775) treatment on adult atopic dermatitis: a randomized placebo-controlled study. Int J Immunopathol Pharmacol. 2011;24(4):1037-48.

Drago L, Toscano M, Vecchi DE, Piconi S, Iemoli E. Changing of fecal flora and clinical effect of L. salivarius LS01 in adults with atopic dermatitis. J Clin Gastroenterol. 2012;46:56-63.

Matsumoto M, Ebata T, Hirooka J, Hosoya R, Inoue N, Itami S, et al. Antipruritic effects of the probiotic strain LKM512 in adults with atopic dermatitis. Ann Allergy Asthma Immunol. 2014;113(2):209-16.

Rather IA, Bajpai VK, Kumar S, Lim J, Paek WK, Park YH. Probiotics and Atopic Dermatitis: An Overview. Frontiers in Microbiol. 2016;7:507.

Frei R, Akdis M, Mahony OL. Prebiotics, probiotics, symbiotic, and the immune system: experimental data and clinical evidence. Curr Opin Gastroenterol. 2015;31(2):153-8.

Enomoto T, Sowa M, Nishimori K, Shimazu S, Yoshida A, Yamada K, et al. Effects of bifidobacterial supplementation to pregnant women and infants in the prevention of allergy development in infants and on fecal microbiota. Allergol Int. 2014;63(4):575-85.

Farid R, Ahanchian H, Jabbari F, Moghiman T. Effect of a new symbiotic mixture on atopic dermatitis in children: a randomized-controlled trial. Iranian J Pediatrics. 2011;21(2):225-30.

Lopez NV, Bosca RA, Vidal RD, Costas RB, Martínez GS, Cuadros CE, et al. Effect of Oral Administration of a Mixture of Probiotic Strains on SCORAD Index and Use of Topical Steroids in Young Patients with Moderate Atopic Dermatitis: A Randomized Clinical Trial. JAMA Dermatol. 2018;154(1):37-43.

Boyle RJ, Hextall BFJ, Bee LJ, Murrell DF, Tang ML. Probiotics for the treatment of eczema: a systematic review. Clin Exp Allergy. 2009;39(8):1117-27.

Kopp MV, Salfeld P. Probiotics and prevention of allergic disease. Curr Opin Clin Nutr Metab Care. 2009;12(3):298-303.

Van DALB, Heymans HS, Aalderen VWM, Smitt SJH, Knol J, Amor BK, et al. The Synbad Study Group. Effect of a new symbiotic mixture on atopic dermatitis in infants: a randomized-controlled trial. Clin Exp Allergy. 2010;40(5):795-804.

Michail SK, Stolfi A, Johnson T, Onady GM. Efficacy of probiotics in the treatment of pediatric atopic dermatitis: a meta-analysis of randomized controlled trials. Ann Allergy Asthma Immunol. 2008;101(5):508-16.






Original Research Articles